Sector revisions CVS Health Corporation

Equities

Market Closed - Nyse Other stock markets 00:00:02 14/05/2026 +04			Pre-market 14:44:10
98.11 ^USD	+3.11%		97.68	-0.44%

01:48pm	Argus Adjusts Price Target on CVS Health to $104 From $90, Maintains Buy Rating	MT
05-14	CVS unit Omnicare wins court approval for $250 million sale to GenieRx	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Visibility	Nbr of analysts
CVS HEALTH CORPORATION				26
HCA HEALTHCARE, INC.				21
FRESENIUS SE & CO. KGAA				14
LABCORP HOLDINGS INC.				17
QUEST DIAGNOSTICS INCORPORATED				16
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY				13
TENET HEALTHCARE CORPORATION				21
REDE D'OR SÃO LUIZ S.A.				13
DAVITA INC.				7
FRESENIUS MEDICAL CARE AG				17
MAX HEALTHCARE INSTITUTE LIMITED				25
UNIVERSAL HEALTH SERVICES, INC.				16
PT SEJAHTERARAYA ANUGRAHJAYA TBK	-	-	-	-
PACS GROUP, INC.				6
CHEMED CORPORATION				4
SOTERA HEALTH COMPANY				8
BUMRUNGRAD HOSPITAL				22
MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.			-	1
CONCENTRA GROUP HOLDINGS PARENT, INC.				7
MEDICOVER AB				6
Average				14
Weighted average by Cap.				19